Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.

Madeleine HetterichMichael GerkenOlaf OrtmannElisabeth C InwaldMonika Klinkhammer-SchalkeHolm EggemannAtanas Ignatov

Published in: Breast cancer research and treatment (2021)

Patients with axillary lymph node micrometastases showed a comparable outcome to node negative patients and their outcome was not significantly improved with CHT. Thus, axillary lymph node micrometastases should not be considered in the treatment decision.

Keyphrases

lymph node
sentinel lymph node
neoadjuvant chemotherapy
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
early stage
young adults
decision making
ultrasound guided
replacement therapy